GNF (May 2025)/ XFTTGNFCMEGL / CME GLOBEX
GNF| 08/01/2025 00:00:00 | Chg. 0.0000 | Bid07/01/2025 | Ask04:04:06 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|---|---|
| 133.2000USD | 0.00% | - | 134.2000 | 133.2000 | 133.2000 | 133.2000 | 133.2000 |
GlobeNewswire
18/01/2024
Genflow Biosciences Partners with Revatis SA and EXO Biologics in Groundbreaking Aging Research, Fue...
GlobeNewswire
16/11/2023
Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red ...
GlobeNewswire
29/08/2023
Freshpet, Inc. to Participate in the Piper Sandler Growth Frontiers Conference
GlobeNewswire
29/08/2023
Freshpet, Inc. to Participate in the Piper Sandler Growth Frontiers Conference
GlobeNewswire
23/09/2021
Cameco, GE Hitachi, GEH SMR Canada and Synthos Green Energy to Collaborate on Potential Deployment o...
GlobeNewswire
07/07/2021
Cameco, GE Hitachi and Global Nuclear Fuel to Examine Potential Collaboration to Support BWRX-300 Sm...
GlobeNewswire
26/07/2019
Global Nuclear Zirconium Alloy Market Report 2019: Analysis of Nuclear-Grade Zirconium Sponge, Alloy...
GlobeNewswire
17/05/2019
Nuclear Industry Value Chain Report 2018: Updated Forecasts for Global Nuclear Power Extended Throug...
GlobeNewswire
14/03/2019
Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospecti...
GlobeNewswire
06/11/2018
Veteran Oncology Biotechnology Executive and Third Rock Ventures Entrepreneur in Residence Markus Wa...
GlobeNewswire
28/11/2013
New malaria target identified with potential to prevent, block, and treat multiple stages of the mal...
GlobeNewswire
17/11/2011
Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential t...
GlobeNewswire
20/07/2007
QIAGEN and the JCSG Announce Agreement for Commercialization of Sample Technologies for Protein Crys...
GlobeNewswire
23/05/2006
Novartis spearheads innovative malaria research project in newly created public-private partnership